Literature DB >> 17574050

Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.

Michael R Freeman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574050     DOI: 10.1016/j.juro.2007.03.203

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.

Authors:  Jianning Sun; Zhu-Lin Yang; Xiongying Miao; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  J Mol Histol       Date:  2014-10-14       Impact factor: 2.611

Review 2.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

3.  Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms.

Authors:  Olgica Trenchevska; Elena Kamcheva; Dobrin Nedelkov
Journal:  J Proteome Res       Date:  2010-09-23       Impact factor: 4.466

4.  Expression kinetics of chicken β2-microglobulin and Class I MHC in vitro and in vivo during Marek's disease viral infections.

Authors:  Chuan Yu; Qiu Liu; Aijian Qin; Xuming Hu; Wencai Xu; Kun Qian; Hongxia Shao; Wenjie Jin
Journal:  Vet Res Commun       Date:  2013-08-06       Impact factor: 2.459

5.  Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma.

Authors:  Qian Jiang; Sdek Patima; Dong-Xia Ye; Hong-Ya Pan; Pin Zhang; Zhi-Yuan Zhang
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

6.  B2M overexpression correlates with malignancy and immune signatures in human gliomas.

Authors:  Hao Zhang; Biqi Cui; Yulai Zhou; Xinxing Wang; Wantao Wu; Zeyu Wang; Ziyu Dai; Quan Cheng; Kui Yang
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.